ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

OLDSMAR, FL—Performance Feeders Inc. has designed a vibratory bowl feeder, 30 inches in diameter, to supply three different ...

Barra's reinvention of General Motors helps her claim the No. 1 spot on Fortune's Most Powerful Women in Business list. The Fortune Recommends top picks for the best high-yield savings accounts ...

Analysts on Wall Street project that ResMed (RMD) will announce quarterly earnings of $2.03 per share in its forthcoming report, representing an increase of 23.8% year over year. Revenues are ...

Learn More ResMed (ASX: RMD) shares are outperforming the market on Tuesday. In afternoon trade, the sleep disorder treatment company's shares are up 2% to $35.73. This compares favourably to a 0. ...

Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for ...

2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem ...

This auto parts retailer has reported consistently increasing ... implying a potential 18% gain from the stock’s recent close. ResMed (RMD, $206). The world’s largest manufacturer of breathing ...

Sleep apnoea devices giant ResMed wants to hit high single-digit revenue growth over the next five years broadening its product range for insomnia and COPD sufferers. The US headquartered company ...

Fisher-Price has recalled two parts of its Snuga Swings and warned parents that the products should not be used for sleep ...

Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...